• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec8
Cardiff Oncology to present new clinical data on onvansertib at ASH annual meeting
21:05
Nov7
Cardiff Oncology released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 120 K (forecast USD 121.43 K), actual EPS USD -0.1684 (forecast USD -0.205)
04:00
Cardiff Oncology released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 350K, actual EPS USD -0.5801
04:00
Jul30
Cardiff Oncology released FY2025 Semi-Annual earnings on July 29 (EST), actual revenue USD 230K, actual EPS USD -0.4117
03:00
Cardiff Oncology released FY2025 Q2 earnings on July 29, 2025 (EST), with actual revenue of USD 121 K (forecast USD 106.25 K) and actual EPS of USD -0.2096 (forecast USD -0.1925)
03:00
Jun26
Cardiff Oncology Annual Shareholder Meeting Appoints Registered Independent Auditor and Amends Equity Incentive Plan
20:31

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 120 K, Net Income -11.26 M, EPS -0.1684

Jul29
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 121 K, Net Income -13.95 M, EPS -0.2096

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 109 K, Net Income -13.44 M, EPS -0.202

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
44.140
+321.18%
+33.660
SRV.RT
0.1496
+252.00%
+0.107
BBGI
11.610
+186.67%
+7.560
ENVB
12.159
+105.38%
+6.220
JMG
7.330
+83.25%
+3.330
BEAT
1.245
+54.56%
+0.435
PLAB
37.460
+45.82%
+11.860
HSPO
23.930
+36.74%
+6.430
CGTL
0.8939
+35.46%
+0.240
BDRX
5.350
+31.45%
+1.310
View More